Polymorphisms of IKBKE gene are associated with major depressive disorder and panic disorder

Brain and Behavior

Volumn 5, Issue 4, 2015, Pages 1-9

  Traks, Tanel ^a,b   Koido, Kati ^a,b   Balõtšev, Roman ^a   Eller, Triin ^a   Kõks, Sulev ^a,b   Maron, Eduard ^a,c   Tõru, Innar ^a   Shlik, Jakov ^d   Vasar, Eero ^a,b   Vasar, Veiko ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b Faculty of Medicine   (Estonia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

IKBKE; SNP; Genetic association study; Major depressive disorder; Panic disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; I KAPPA B KINASE EPSILON; I KAPPA B KINASE; IKBKE PROTEIN, HUMAN;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IKBKE GENE; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NEUROENDOCRINE SYSTEM; PANIC; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MAJOR DEPRESSION; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; I-KAPPA B KINASE; MALE; MIDDLE AGED; PANIC DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84926526782     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.314     Document Type: Article

References (60)

1. Adli, M., and A. S. Baldwin. 2006. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J. Biol. Chem. 281:26976-26984.
2. Andrade, L., J. J. Caraveo-Anduaga, P. Berglund, R. V. Bijl, R. De Graaf, W. Vollebergh, et al. 2003. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int. J. Methods Psychiatr. Res. 12:3-21.
3. de Bakker, P. I., R. Yelensky, I. Pe'er, S. B. Gabriel, M. J. Daly, and D. Altshuler 2005. Efficiency and power in genetic association studies. Nat. Genet. 37:1217-1223.
4. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Boehm, J. S., J. J. Zhao, J. Yao, S. Y. Kim, R. Firestein, I. F. Dunn, et al. 2007. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129:1065-1079.
6. Bosker, F. J., C. A. Hartman, I. M. Nolte, B. P. Prins, P. Terpstra, D. Posthuma, et al. 2011. Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol. Psychiatry 16:516-532.
7. Bufalino, C., N. Hepgul, E. Aguglia, and C. M. Pariante. 2013. The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav. Immun. 31:31-47.
8. Capuron, L., and A. H. Miller. 2011. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 130:226-238.
9. Detera-Wadleigh, S. D., J. A. Badner, W. H. Berrettini, T. Yoshikawa, L. R. Goldin, G. Turner, et al. 1999. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc. Natl Acad. Sci. USA 96:5604-5609.
10. Dieguez-Gonzalez, R., S. Akar, M. Calaza, E. Perez-Pampin, J. Costas, M. Torres, et al. 2009. Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis. Ann. Rheum. Dis. 68:579-583.
11. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, et al. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496.
12. Gelernter, J., K. Bonvicini, G. Page, S. W. Woods, A. W. Goddard, S. Kruger, et al. 2001. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am. J. Med. Genet. 105:548-557.
13. Gorman, J. M., J. M. Kent, G. M. Sullivan, and J. D. Coplan. 2000. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 157:493-505.
14. Grant, B. F., D. S. Hasin, F. S. Stinson, D. A. Dawson, R. B. Goldstein, S. Smith, et al. 2006. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 67:363-374.
15. Guan, H., H. Zhang, J. Cai, J.Wu, J. Yuan, J. Li, et al. 2011. IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-kappaB. J. Pathol. 223:436-445.
16. Guo, J. P., S. K. Shu, L. He, Y. C. Lee, P. A. Kruk, S. Grenman, et al. 2009. Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am. J. Pathol. 175:324-333.
17. Gurling, H. M., G. Kalsi, J. Brynjolfson, T. Sigmundsson, R. Sherrington, B. S. Mankoo, et al. 2001. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am. J. Hum. Genet. 68:661-673.
18. Haroon, E., C. L. Raison, and A. H. Miller. 2012. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137-162.
19. Harris, J., S. Oliere, S. Sharma, Q. Sun, R. Lin, J. Hiscott, et al. 2006. Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon. J. Immunol. 177:2527-2535.
20. Hemmi, H., O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, et al. 2004. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:1641-1650.
21. Hettema, J. M., M. C. Neale, J. M. Myers, C. A. Prescott, and K. S. Kendler. 2006. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am. J. Psychiatry 163:857-864.
22. Hoge, E. A., K. Brandstetter, S. Moshier, M. H. Pollack, K. K. Wong, and N. M. Simon. 2009. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 26:447-455.
23. Ishii, K. J., C. Coban, H. Kato, K. Takahashi, Y. Torii, F. Takeshita, et al. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7:40-48.
24. Johnson, M. R., and R. B. Lydiard. 1998. Comorbidity of major depression and panic disorder. J. Clin. Psychol. 54:201-210.
25. Keck, M. E., N. Kern, A. Erhardt, P. G. Unschuld, M. Ising, D. Salyakina, et al. 2008. Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B:1196-1204.
26. Kendler, K. S., C. O. Gardner, M. C. Neale, and C. A. Prescott. 2001. Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes? Psychol. Med. 31:605-616.
27. Kendler, K. S., M. Gatz, C. O. Gardner, and N. L. Pedersen. 2006. A Swedish national twin study of lifetime major depression. Am. J. Psychiatry 163:109-114.
28. Kessler, R. C., P. Berglund, O. Demler, R. Jin, K. R. Merikangas, and E. E. Walters. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62:593-602.
29. Kessler, R. C., W. T. Chiu, R. Jin, A. M. Ruscio, K. Shear, and E. E. Walters. 2006. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 63:415-424.
30. Kohli, M. A., S. Lucae, P. G. Saemann, M. V. Schmidt, A. Demirkan, K. Hek, et al. 2011. The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 70:252-265.
31. Koido, K., T. Eller, K. Kingo, S. Koks, T. Traks, J. Shlik, et al. 2010. Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. J. Psychiatr. Res. 44:275-277.
32. Koo, J. W., S. J. Russo, D. Ferguson, E. J. Nestler, and R. S. Duman. 2010. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl Acad. Sci. USA 107:2669-2674.
33. Kravchenko, V. V., J. C. Mathison, K. Schwamborn, F. Mercurio, and R. J. Ulevitch. 2003. IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli. J. Biol. Chem. 278:26612-26619.
34. Lee, P. Y., Y. Li, Y. Kumagai, Y. Xu, J. S. Weinstein, E. S. Kellner, et al. 2009. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am. J. Pathol. 175:2023-2033.
35. Loftis, J. M., M. Huckans, and B. J. Morasco. 2010. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol. Dis. 37:519-533.
36. Lohoff, F. W. 2010. Overview of the genetics of major depressive disorder. Curr. Psychiatry Rep. 12:539-546.
37. Maron, E., J. M. Hettema, and J. Shlik. 2010. Advances in molecular genetics of panic disorder. Mol. Psychiatry 15:681-701.
38. Mattioli, I., H. Geng, A. Sebald, M. Hodel, C. Bucher, M. Kracht, et al. 2006. Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J. Biol. Chem. 281:6175-6183.
39. Mosing, M. A., S. D. Gordon, S. E. Medland, D. J. Statham, E. C. Nelson, A. C. Heath, et al. 2009. Genetic and environmental influences on the co-morbidity between depression, panic disorder, agoraphobia, and social phobia: a twin study. Depress Anxiety 26:1004-1011.
40. Otowa, T., E. Yoshida, N. Sugaya, S. Yasuda, Y. Nishimura, K. Inoue, et al. 2009. Genome-wide association study of panic disorder in the Japanese population. J. Hum. Genet. 54:122-126.
41. Otowa, T., H. Tanii, N. Sugaya, E. Yoshida, K. Inoue, S. Yasuda, et al. 2010. Replication of a genome-wide association study of panic disorder in a Japanese population. J. Hum. Genet. 55:91-96.
42. Park, J. E., S. W. Kim, Q. Park, D. U. Jeong, and B. H. Yu. 2005. Lymphocyte subsets and mood states in panic disorder patients. J. Korean Med. Sci. 20:215-219.
43. Peters, R. T., and T. Maniatis. 2001. A new family of IKK-related kinases may function as I kappa B kinase kinases. Biochim. Biophys. Acta 1471:M57-M62.
44. Sandelin, A., W. W. Wasserman, and B. Lenhard. 2004. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 32:W249-W252.
45. Sandling, J. K., S. Garnier, S. Sigurdsson, C. Wang, G. Nordmark, I. Gunnarsson, et al. 2011. A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eur. J. Hum. Genet. 19:479-484.
46. Sankar, S., H. Chan, W. J. Romanow, J. Li, and R. J. Bates. 2006. IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines. Cell. Signal. 18:982-993.
47. Schumacher, J., A. S. Kristensen, J. R. Wendland, M. M. Nothen, O. Mors, and F. J. McMahon. 2011. The genetics of panic disorder. J. Med. Genet. 48:361-368.
48. Seo, S. I., S. Y. Song, M. R. Kang, M. S. Kim, J. E. Oh, Y. R. Kim, et al. 2009. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers. APMIS 117:623-628.
49. Sharma, S., B. R. ten Oever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151.
50. Sheehan, D. V., Y. Lecrubier, K. H. Sheehan, P.Amorim, J. Janavs, E. Weiller, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl 20):22-33; quiz 34-57.
51. Shimada, T., T. Kawai, K. Takeda, M. Matsumoto, J. Inoue, Y. Tatsumi, et al. 1999. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int. Immunol. 11:1357-1362.
52. Smoller, J. W., J. S. Jr Acierno, J. F. Rosenbaum, J. Biederman, M. H. Pollack, S. Meminger, et al. 2001. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am. J. Med. Genet. 105:195-206.
53. Sullivan, P. F., M. C. Neale, and K. S. Kendler. 2000. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157:1552-1562.
54. Sweeney, S. E., D. Hammaker, D. L. Boyle, and G. S. Firestein. 2005. Regulation of c-Jun phosphorylation by the I kappa B kinase-epsilon complex in fibroblast-like synoviocytes. J. Immunol. 174:6424-6430.
55. Taniguchi, T., and A. Takaoka. 2002. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14:111-116.
56. Tobler, A. R., S. Short, M. R. Andersen, T. M. Paner, J. C. Briggs, S. M. Lambert, et al. 2005. The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J. Biomol. Tech. 16:398-406.
57. Wang, N., S. Ahmed, and T. M. Haqqi. 2005. Genomic structure and functional characterization of the promoter region of human IkappaB kinase-related kinase IKKi/IKKvarepsilon gene. Gene 353:118-133.
58. van West, D., J. Del-Favero, Y. Aulchenko, P. Oswald, D. Souery, T. Forsgren, et al. 2004. A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression. Mol. Psychiatry 9:287-292.
59. Wray, N. R., M. R. James, S. P. Mah, M. Nelson, G. Andrews, P. F. Sullivan, et al. 2007. Anxiety and comorbid measures associated with PLXNA2. Arch. Gen. Psychiatry 64:318-326.
60. Zubenko, G. S., B. Maher, H. B. 3rd Hughes, W. N.Zubenko, J. S. Stiffler, B. B. Kaplan, et al. 2003. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 123B:1-18.